NCT02918747 2020-01-28PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early StageHunan Cancer HospitalPhase 2 Unknown100 enrolled
NCT01307592 2014-01-10Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2 Unknown70 enrolled